ACIW vs ITRI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ACIW's Piotroski F-Score of 4/9 indicates weak financial health, signaling deterioration in operational efficiency and profitability trends. The company trades at a premium to its Graham Number ($26.81) and intrinsic value ($15.12), suggesting overvaluation despite solid gross margins and ROE. Recent earnings have declined sharply year-over-year (-33.3%) and quarter-over-quarter (-34.7%), with a negative EPS trend and inconsistent beat rates. Insider selling activity, though limited, adds bearish sentiment. Despite strong analyst consensus (strong_buy), technical trends remain bearish and price has underperformed over the past year.
ITRI exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a highly attractive valuation profile, trading significantly below its growth-based intrinsic value of $191.75. While the technical trend is bearish and insider sentiment is low, the company's profitability is robust with an ROE of 19.26% and a PEG ratio of 0.82, indicating the stock is undervalued relative to its earnings growth. The primary concern is a recent decline in revenue growth (-6.70%), though this is heavily offset by massive earnings growth (73.60%) and a consistent track record of earnings beats. Overall, the data suggests a value-driven entry point for a company with strong operational efficiency.
Compare Another Pair
Related Comparisons
ACIW vs ITRI: Head-to-Head Comparison
This page compares ACI Worldwide, Inc. (ACIW) and Itron, Inc. (ITRI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.